What is MBRX's dilution risk score?

MBRX has a latest available DilutionScore record of 80/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MBRX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MBRX?

DilutionWatch tracks 25 SEC filing types for MBRX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MBRX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MBRX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MBRX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MBRX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MBRX Dilution Risk Score: 80/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

85

📊 Float Risk

75

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 34%

💰 Capital Raise model 53%

• Low cash runway: 4 months remaining

• Active ATM program with $15M remaining capacity

🔄 Reverse Split model est. 15%

• Only 4 months cash — financial pressure

📉 Score Deterioration model 15%

• Score already CRITICAL (80/100) — events likely imminent

🔔 Track MBRX — Get forecast alerts →

Market Data

Market Cap$14.89M

Shares Outstanding19.48M

Float5.29M

Cash$7.26M

Debt$326.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 378.2% shares (2026Q1 vs prior)

3 institutional holders · 1.3K shares

#1 MORGAN STANLEY 926 shares

#2 BARCLAYS PLC 344 shares

#3 DANSKE BANK A/S 2 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.58M

Days to Cover1.0

% of Float29.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2018-12-31

8-K 8K EVENT 2026-06-30

4 INSIDER TRANSACTION 2026-06-24

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual MBRX Dilution Snapshot

Moleculin Biotech, Inc. (MBRX) has a DilutionScore of 80/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $15.3M.
Stored outstanding warrants: 107,802.
Recent SEC activity tracked for MBRX: 8-K on 2026-06-30; 4 on 2026-06-24; 4 on 2026-06-24.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.